ETF

VanEck Genomics and Healthcare Inn ETF GBP

ISIN
IE000B9PQW54

How good is this fund, really?

See the rating in the app

About VanEck Genomics and Healthcare Inn ETF GBP

Gene-based therapies, mRNA and the tools behind them, plus digital health, define the MVIS Global Future Healthcare ESG Index. VanEck Genomics and Healthcare Innovators UCITS ETF replicates it, owning shares of firms that earn at least 50% of revenue (25% once in the index) from genetic therapies, enabling technology platforms, related lab equipment and services, online consultation software, e-commerce pharmacies, practice and patient-record software, or remote health-monitoring devices. ESG factors are part of the index method and the fund is classified under SFDR Article 9. A sub-fund of VanEck UCITS ETFs plc managed by VanEck Asset Management B.V., it accumulates income and does not lend securities. Launched on 2 September 2022. Charges run at 0.35% a year; the risk ranking is 6 of 7, with a five-year minimum horizon suggested.

Watch this fund for free Add VanEck Genomics and Healthcare Inn ETF GBP to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy VanEck Genomics and Healthcare Inn ETF GBP — platforms and fees

Sold on 2 platforms we follow.

VanEck Genomics and Healthcare Inn ETF GBP — its category

Sector Equity Healthcare — PowerFunds rates 229 funds in this category every month.

Healthcare funds →

Other funds